Rating papilloedema: An evaluation of the Frisén classification in idiopathic intracranial hypertension

Journal of Neurology

Volumn 259, Issue 7, 2012, Pages 1406-1412

  Sinclair, Alexandra J ^a   Burdon, Michael A ^a,b   Nightingale, Peter G ^a   Matthews, Timothy D ^b   Jacks, Andrew ^b   Lawden, Mark ^c   Sivaguru, Arul ^d   Gaskin, Brent J ^b,e   Rauz, Saaeha ^a   Clarke, Carl E ^a,d   Ball, Alexandra K ^a,f  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c LEICESTER GENERAL HOSPITAL   (United Kingdom)

^d CITY HOSPITAL   (United Kingdom)

^e GREEN LANE HOSPITAL   (New Zealand)

^f HAYWOOD HOSPITAL   (United Kingdom)

Author keywords

Fris n classification; Grading; Idiopathic intracranial hypertension; Papilloedema

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DISEASE CLASSIFICATION; DISEASE SEVERITY; FRISEN CLASSIFICATION; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; INTERMETHOD COMPARISON; NEUROOPHTHALMOLOGY; OPTIC DISK; OPTIC DISK RANKING; PAPILLEDEMA; PHOTOGRAPHY; PRIORITY JOURNAL; RATING SCALE; REPRODUCIBILITY;

FEMALE; HUMANS; MALE; OPHTHALMOSCOPY; OPTIC DISK; PAPILLEDEMA; PSEUDOTUMOR CEREBRI; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84864286186     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6365-6     Document Type: Article

References (10)

1. Ball AK, Clarke CE (2006) Idiopathic intracranial hypertension. Lancet Neurol 5(5):433-442
2. Frisen L (1982) Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psych 45:13-18 (Pubitemid 12171775)
3. Wall M, George D (1991) Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain 114:155-180
4. Celebisoy N, Gokcay F, Sirin H, Akyurekli O (2007) Treatment of idiopathic intracranial hypertension: topiramate versus acetazolamide, an open-label study. Acta Neurol Scand 116(5): 322-327 (Pubitemid 47537419)
5. Shah VA, Kardon RH, Lee AG, Corbett JJ, Wall M (2008) Longterm follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology 70(8):634-640 (Pubitemid 351294641)
6. Bruce BB, Kedar S, Van Stavern GP, Monaghan D, Acierno MD, Braswell RA, Preechawat P, Corbett JJ, Newman NJ, Biousse V (2009) Idiopathic intracranial hypertension in men. Neurology 72(4):304-309
7. Ball A, Howman A, Wheatley K, Burdon M, Matthews T, Jacks A, Lawden M, Sivaguru A, Furmston A, Howell S, Sharrack B, Davies M, Sinclair A, Clarke C (2011) A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol 258(5):874-881
8. Sinclair A, Burdon M, Ball A, Nightingale N, Good P, Matthews T, Jacks A, Lawden M, Clarke C, Walker E, Tomlinson J, Stewart P, Rauz S (2010) Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 7:341
9. Kupersmith M, Gamell L, Turbin R, Peck V, Spiegel P, Wall M (1998) Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 50:1094-1098 (Pubitemid 28212843)
10. Johnson LN, Krohel GB, Madsen RW, March GA Jr (1998) The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 105(12):2313-2317 (Pubitemid 30191677)